In yesterday’s Wall Street session, Colgate-Palmolive Co. (NYSE:CL) shares traded at $75.98, up 0.68% from the previous session.
As of this writing, 23 analysts cover Colgate-Palmolive Co. (NYSE:CL). The consensus rating among analysts is ‘Overweight’. As we calculate the median target price by taking the range between a high of $90.00 and a low of $75.00, we find $83.50. Given the previous closing price of $75.47, this indicates a potential upside of 10.64 percent. CL stock price is now 4.36% away from the 50-day moving average and 1.37% away from the 200-day moving average. The market capitalization of the company currently stands at $62.56B.
There are 11 analysts who have given it a hold rating, whereas 12 have given it a buy rating. Brokers who have rated the stock have averaged $81.84 as their price target over the next twelve months.
With the price target of $87, Jefferies recently initiated with Buy rating for Colgate-Palmolive Co. (NYSE: CL).
In other news, CAHILL JOHN T, Director sold 6,329 shares of the company’s stock on Nov 03. The stock was sold for $474,170 at an average price of $74.92. Upon completion of the transaction, the Director now directly owns 24,686 shares in the company, valued at $1.88 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 03, Chief of Staff Kooyman John W sold 3,000 shares of the business’s stock. A total of $225,330 was realized by selling the stock at an average price of $75.11. This leaves the insider owning 5,347 shares of the company worth $0.41 million. Insiders disposed of 434,680 shares of company stock worth roughly $33.03 million over the past 1 year. A total of 0.14% of the company’s stock is owned by insiders.
Thursday morning saw Colgate-Palmolive Co. (NYSE: CL) opened at $75.57. During the past 12 months, Colgate-Palmolive Co. has had a low of $67.62 and a high of $82.09. According to the stock market information, the enterprise value for the company is $69.91B, which is based on a 39.73 price-to-earnings ratio, a 5.30 price-to-earnings-growth ratio, and a beta of 0.43. The fifty day moving average price for CL is $72.86 and a two-hundred day moving average price translates $74.96 for the stock.
The latest earnings results from Colgate-Palmolive Co. (NYSE: CL) was released for Sep, 2023. According to the Household & Personal Products Company, earnings per share came in at $0.86, beating analysts’ expectations of $0.8 by 0.06. This compares to $0.81 EPS in the same period last year. The net profit margin was 8.29% and return on equity was 517.78% for CL. The company reported revenue of $4.92 billion for the quarter, compared to $4.46 billion a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 10.33 percent. For the current quarter, analysts expect CL to generate $4.87B in revenue.
Colgate-Palmolive Co.(CL) Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items. This segment markets and sells its products under various brands, which include Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom’s of Maine, Irish Spring, Palmolive, Protex, Sanex, Softsoap, Lady Speed Stick, Speed Stick, EltaMD, Filorga, PCA SKIN, Ajax, Axion, Fabuloso, Murphy, Suavitel, Soupline, and Cuddly to a range of traditional and eCommerce retailers, wholesalers, and distributors. It also includes pharmaceutical products for dentists and other oral health professionals. The Pet Nutrition segment offers pet nutrition products for everyday nutritional needs under the Hill’s Science Diet brand; and a range of therapeutic products to manage disease conditions in dogs and cats under the Hill’s Prescription Diet brand. This segment markets and sells its products through pet supply retailers, veterinarians, and eCommerce retailers. Colgate-Palmolive Company was founded in 1806 and is headquartered in New York, New York.